L
Lantern Pharma Inc. (LTRN)
NCM – Real Time Price. Currency in USD
2.06
-0.03 (-1.44%)
At close: May 12, 2026, 4:00 PM EDT
2.06
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.06
-0.03 (-1.44%)
At close: May 12, 2026, 4:00 PM EDT
2.06
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.40 | 6.05 | 10 | |
| Quick ratio | 2.40 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -155K | -175K | -190K | -17K | -17K |
| Operating Income | -14M | -18M | -22M | -18M | -18M |
| Net Income | -14M | -16M | -21M | -17M | -17M |
| EBITDA | -14M | -18M | -22M | -18M | -18M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 14.29 | 4.5 |
| Next quarter | N/A | 5 | 2.5 |
| Current year | N/A | -10.83 | 1.0 |
| Next year | N/A | -16.09 | 1.0 |
| Weighted average score | 2.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 2.47 | 7.69 | 38.94 | 7.3 |
| Y/Y | 999 | 30.65 | 33.33 | 29.76 | 10 |
| 3y average | 999 | -8.15 | -8.27 | -8.09 | 3.3 |
| 5y average | 999 | -29.8 | -4.64 | -26.4 | 3.3 |
| Weighted average score | 6.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $4.4M significantly exceed its total debt $78.5K, ensuring strong financial flexibility
Total current assets $10.8M exceed Total current liabilities $4.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$2.8M limits the company's ability to reinvest or pay down debt